Begin main content

Open Calls for Patient Input

This page lists Common Drug Review (CDR) drug applications received by CADTH and the deadlines for filing patient group input for each drug. For more information about how to provide input, please visit the CDR Patient Input page

TBC (Dolutegravir / rilpivirine)

Indications: HIV infection

Call For Patient Input: November 23, 2017

Patient Input Closed: January 19, 2018

Iluvien (fluocinolone acetate)

Indications: Diabetic macular edema (DME)

Call For Patient Input: November 22, 2017

Patient Input Closed: January 18, 2018

Probuphine (buprenorphine hydrochloride)

Indications: Opioid drug dependence, treatment

Call For Patient Input: November 22, 2017

Patient Input Closed: January 18, 2018

Akynzeo (netupitant / palonosetron)

Indications: Nausea and vomiting (chemotherapy induced) prevention

Call For Patient Input: November 16, 2017

Patient Input Closed: January 12, 2018

TBC (brodalumab)

Indications: Psoriasis, moderate to severe plaque

Call For Patient Input: November 8, 2017

Patient Input Closed: January 4, 2018

TBC (cladribine )

Indications: Multiple Sclerosis, relapsing

Call For Patient Input: November 3, 2017

Patient Input Closed: December 22, 2017

TBC (letermovir)

Indications: Cytomegalovirus infection, prophylaxis

Call For Patient Input: November 3, 2017

Patient Input Closed: December 22, 2017